Cybin (CYBN) Stock Forecast & Price Target

CYBN$8.28+0.10 +1.22%
Biotechnology
Compare
Market cap$413.02MEnterprise value$358.16MRevenue (TTM)$0Market position—

Score

52
Neutral
Value
57
Quality
50
Growth
50

Cybin Inc. analyst ratings

RatingAnalysts
Strong buy0
Buy4
Hold0
Sell0
Strong sell0
ConsensusBuy

4 analysts cover CYBN.

Cybin Inc. EPS and revenue estimates

CYBN shows the next fiscal years with at least three analysts: 2026 EPS $-4.38, 2027 EPS $-3.40. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-4.38—
2027$-3.40$12.51M

Is Cybin Inc. a buy or sell?

Of the 4 analysts covering Cybin Inc., 4 rate it a buy (0 strong buy and 4 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The CYBN consensus label is Buy, beside 4 buy-side ratings and 0 sell-side ratings.

Those 4 ratings on CYBN are a headcount, and the label on file is Buy.

Reading the Cybin Inc. forecast

Ratings on the Cybin Inc. cluster: 4 of 4 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.

The CYBN EPS path from 2026 ($-4.38) to 2027 ($-3.40) is rising.

Only 4 analysts cover CYBN, so the average rests on a short list.

Cybin Inc. forecast questions

What is the CYBN price target?

No average price target is on file for CYBN.

Is Cybin Inc. a buy or sell?

Of the 4 analysts covering Cybin Inc., 4 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the CYBN headcount is 4 buy, 0 hold, and 0 sell.

What is the EPS estimate for Cybin Inc.?

Analyst EPS estimates for Cybin Inc.: 2026 $-4.38, 2027 $-3.40.

What is the revenue estimate for Cybin Inc.?

Analyst revenue estimates for Cybin Inc.: 2027 $12.51M.

How many analysts cover CYBN?

4 analysts cover CYBN. Their consensus on CYBN is Buy, across those 4.

CYBN price $8.28 +0.10 +1.22%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener